Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05509595 |
|---|---|
| Brief Title: | Burosumab for Fibroblast Growth Factor-23 Mediated Hypophosphatemia in Fibrous Dysplasia |
| First Submitted : | August 19, 2022 |
| First Submitted that Met QC Criteria : | August 19, 2022 |
| First Posted : | August 22, 2022 |
| Last Update Submitted that Met QC Criteria : | March 16, 2024 |
| Last Update Posted : | March 19, 2024 |